Noble Financial Lifts PT on TherapeuticsMD (TXMD) to $15; Sees Reduced TX 12-001HR Risk

March 11, 2015 11:47 AM

Noble Financial affirms TherapeuticsMD, Inc. (AMEX: TXMD) at Buy and nudges its price target from $14 up to $15 following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found